Search

everythinglearnresearchcommunity

for

Search:↓

A child with low platelets and anemia was later found to have lupus.

About 8% of people with systemic lupus erythematosus have chronic scarring alopecia, with certain symptoms and positive antibodies increasing the risk, while immunosuppressants may lower it.

Recognizing unusual brain and skin symptoms is crucial for diagnosing lupus early.

Oral ulcers are common in SLE patients and often link to other symptoms.

Hair changes can indicate systemic diseases or medication effects.

Using minoxidil and tofacitinib together can effectively treat severe hair loss.

Gender-specific analysis could improve treatment for childhood systemic lupus erythematosus.

NEMO syndrome and systemic lupus erythematosus are linked in a new disease association.

Some men taking finasteride for hair loss may experience sexual problems like erectile dysfunction and decreased sex drive, which can persist even after stopping the medication.

Early diagnosis, intensive therapy, and careful follow-up are crucial for managing overlapping TTP and SLE.

Tofacitinib is somewhat effective for alopecia areata, but more research is needed on its safety and long-term effects.

Oral cyclosporine is more effective and safer than betamethasone for treating alopecia areata.

A girl with lupus had unusually long and thick eyelashes, a rare symptom of her condition.

A patient with lupus and long-term hair loss saw significant hair regrowth after using the drug tofacitinib.

New treatments for severe alopecia areata, especially JAK inhibitors, are recommended as first-line therapy.

Patients with certain skin symptoms and high ANA titers should be monitored for potential systemic lupus.

Hair follicles may soon be used more for targeted and systemic drug delivery.

Cyclosporine showed some improvement in alopecia areata but results were not statistically significant.

A 5-year-old boy's skin condition improved with systemic valganciclovir after a cardiac transplant and immunosuppressive therapy.

Patients with chronic skin conditions on systemic treatments did not have worse COVID-19 outcomes and could resume their treatments after recovery.

A mother and son both had ulcerative colitis and alopecia, suggesting a genetic link in autoimmune disorders and successful treatment with cyclosporine.

Thalidomide works best for skin lupus not helped by antimalarials, but has many side effects; other treatments are less effective, especially if patients also have systemic lupus.

Early treatment and regular check-ups are crucial for lupus patients to prevent progression and improve outcomes.

Compounded topical preparations should be used with caution for severe psoriasis and generally come after systemic treatments.

Platelet-rich plasma injections can help treat hair loss in lupus patients.

Alopecia areata treatment should be personalized, using topical or systemic therapies based on severity, with promising options like JAK inhibitors needing more research.

Anifrolumab treatment improves quality of life and reduces disease activity and steroid use in SLE patients.

Tofacitinib is a safe treatment for hair loss in children, but long-term use may be needed for best results.

Some systemic treatments work for nail psoriasis but can have serious side effects.

Cyclosporine-A can cause serious blood clots in the brain, so patients need careful monitoring.